Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial.

Mecinaj, A; Gulati, G; Heck, S L; Holte, E; Fagerland, M W; Larsen, A I; Blix, E S; Geisler, J; Wethal, T; Omland, T

Mecinaj, A; Gulati, G; Heck, S L; Holte, E; Fagerland, M W; Larsen, A I; Blix, E S; Geisler, J; Wethal, T; Omland, T.

Afiliação

Mecinaj A; Department of Cardiology, Division of Medicine, Akershus University Hospital, Sykehusveien 25, 1478, Lørenskog, Norway.
Gulati G; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Heck SL; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Holte E; Division of Research and Innovation, Akershus University Hospital, Lørenskog, Norway.
Fagerland MW; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Larsen AI; Department of Diagnostic Imaging, Akershus University Hospital, Lørenskog, Norway.
Blix ES; Clinic of Cardiology, St. Olavs Hospital, Trondheim, Norway.
Geisler J; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology NTNU, Trondheim, Norway.
Wethal T; Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.
Omland T; Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.